London Daily

Focus on the big picture.
Thursday, Jun 11, 2026

Despite Hi-Tech Advances, Many Europeans Wary Of Taking Covid Shot

Despite Hi-Tech Advances, Many Europeans Wary Of Taking Covid Shot

The European Union has secured contracts with a range of drugmakers including Pfizer and BioNTech, Moderna and AstraZeneca, for a total of more than two billion doses and has set a goal for all adults to be inoculated next year.

Europe rolled out a huge COVID-19 vaccination drive on Sunday to try to rein in the coronavirus pandemic but many Europeans are sceptical about the speed at which the vaccines have been tested and approved and reluctant to have the shot.

The European Union has secured contracts with a range of drugmakers including Pfizer and BioNTech, Moderna and AstraZeneca, for a total of more than two billion doses and has set a goal for all adults to be inoculated next year.

But surveys have pointed to high levels of hesitancy towards inoculation in countries from France to Poland, with many used to vaccines taking decades to develop, not just months.

"I don't think there's a vaccine in history that has been tested so quickly," Ireneusz Sikorski, 41, said as he stepped out of a church in central Warsaw with his two children.

"I am not saying vaccination shouldn't be taking place. But I am not going to test an unverified vaccine on my children, or on myself."

Surveys in Poland, where distrust in public institutions runs deep, have shown fewer than 40% of people planning to get vaccinated, for now. On Sunday, only half the medical staff in a Warsaw hospital where the country's first shot was administered had signed up.

In Spain, one of Europe's hardest-hit countries, German, a 28-year-old singer and music composer originally from Tenerife, also plans to wait for now.

"No one close to me has had it (COVID-19). I'm obviously not saying it doesn't exist because lots of people have died of it, but for now I wouldn't have it (the vaccine)."

A Christian Orthodox bishop in Bulgaria, where 45% of people have said they would not get a shot and 40% plan to wait to see if any negative side effects appear, compared COVID-19 to polio.

"Myself, I am vaccinated against everything I can be," Bishop Tihon told reporters after getting his shot, standing alongside the health minister in Sofia.

He spoke about anxiety over polio before vaccination became available in the 1950s and 1960s.

"We were all trembling in fear of catching polio. And then we were overjoyed," he said. "Now, we have to convince people. It's a pity."

GREAT LEAP FORWARD


The widespread hesitancy does not appear to take into account the scientific developments in recent decades.

The traditional method of creating vaccines ~CHECK~ introducing a weakened or dead virus, or a piece of one, to stimulate the body's immune system ~CHECK~ takes over a decade on average, according to a 2013 study. One pandemic flu vaccine took over eight years while a hepatitis B vaccine was nearly 18 years in the making.

Moderna's vaccine, based on the so-called messenger ribonucleic acid (mRNA) technology, went from gene sequencing to the first human injection in 63 days.

"We'll look back on the advances made in 2020 and say: 'That was a moment when science really did make a leap forward'," said Jeremy Farrar, director of the Oxford University Clinical Research Unit, which is backed by the Wellcome Trust.

The Pfizer/BioNTech shot has been linked with a few cases of severe allergic reactions as it has been rolled out in the United Kingdom and the United States. It has not turned up any serious long-term side effects in clinical trials.

Independent pollster Alpha Research said its recent survey suggested that fewer than one in five Bulgarians from the first groups to be offered the vaccine - frontline medics, pharmacists, teachers and nursing home staff - planned to volunteer to get a shot.

An IPSOS survey of 15 countries published on Nov. 5 showed then that 54% of French would have a COVID vaccine if one were available. The figure was 64% in Italy and Spain, 79% in Britain and 87% in China.

A later IFOP poll - which did not have comparative data for other countries - showed that only 41% people in France would take the shot.

In Sweden, where public trust in authorities runs high like elsewhere across the Nordics, more than two people in three want to be immunised. Still, some say no.

"If someone gave me 10 million euro, I wouldn't take it," Lisa Renberg, 32, said on Wednesday.

Polish Prime Minister Mateusz Morawiecki urged Poles on Sunday to sign up for vaccination, saying the herd immunity effect depended on them.

Critics have said Warsaw's nationalist leaders have been too accepting of anti-vaccination attitudes in the past in an effort to garner conservative support.

Comments

Paul 5 year ago
Why is the words “CHECK” in the article as if the author is not certain of vaccine development methods?
MHogan 5 year ago
How can any logical-thinking person be convinced by the statement: “It [vaccine testing] has not turned up any serious long-term side effects in clinical trials” when clinical trials were but a few months? This is an insult to intelligence; no wonder we have vaccine hesitancy and refusal!

Newsletter

Related Articles

0:00
0:00
Close
Office for National Statistics Adopts Supermarket Checkout Data for Inflation Measurement
Applied Atomics Launches With $500 Million Space Infrastructure Order Book
BYD Plans Nationwide Rollout of Ultra-Fast EV Charging Network
UK House Prices Unexpectedly Fall in May
CBI Warns UK Growth Is Becoming Increasingly Dependent on Public Spending
Makerfield By-Election Fuels Speculation Over Labour’s Future Leadership
Britain Declines to Join EU SAFE Defence Fund
UK Unveils 2040 Emissions Target Despite Strong Political Opposition
Government Orders Full Review of Palantir’s NHS Data Contract
UK Borrowing Costs Climb as Markets Price in Further Bank of England Rate Rises
Resident Doctors Confirm Five-Day NHS Strike Across England
Violent Anti-Immigrant Riots in Belfast Spark Political and Diplomatic Tensions
United Kingdom Sees Recovery in Horizon Europe Research Funding Share to 9.3 Percent
UK Inflation Holds at 2.8 Percent as Office for Budget Responsibility Flags Persistent Price Pressures
United Kingdom Launches National Anti-Fraud Framework to Combat Rising Pension Scam Losses
United Kingdom Expands Sanctions on Israeli Groups While Funding Palestinian Authority Salaries and Gaza Mine Clearance
United Kingdom Issues Three-Month Ultimatum to Major Technology Firms Over Child Online Safety Controls
United Kingdom Government Moves Toward Blanket Social Media Ban for Children Under Sixteen
Widespread Anti-Immigration Rioting Erupts Across Belfast After Knife Attack Linked to Asylum Seeker
Farmers Warn of Crop Losses Following Months of Unseasonal Rainfall
Civil Aviation Authority Launches Review of Regional Airport Operations
Met Office Issues Heat-Health Alert Across Parts of England
National Grid Introduces New Measures to Protect Winter Energy Supply
Northern England Rail Upgrades Receive Additional Government Funding
Wales Advances Green Hydrogen Strategy to Decarbonize Heavy Industry
UK Expands Recruitment Incentives to Address Shortage of STEM Teachers
High Court Opens Door to Climate Liability Claims Against Major Industrial Emitters
Police Service of Northern Ireland Investigates Major Personnel Data Breach
Defense Ministry Overhauls Procurement System to Accelerate AUKUS Submarine Program
Net Migration Remains Above Government Expectations, New Data Shows
UK and Scottish Governments Agree Framework for Expanded North Sea Wind Development
UK Treasury Launches New Tax Incentives to Boost AI and Semiconductor Investment
Bank of England Signals Continued Caution on Interest Rate Cuts
UK Unveils £10 Billion NHS Digital Modernization Plan Centered on AI Integration
Nebius Opens Major Robotics and Physical AI Laboratory in London
Bank of England Data Shows Strong Rise in New Mortgage Approvals
Network Rail Completes Landmark Upgrade of Severn Tunnel Rail Infrastructure
East West Rail Passenger Services Between Oxford and Milton Keynes Set for December Launch
GlaxoSmithKline Reportedly Pursues £7 Billion Acquisition of US Cancer Drug Developer Nuvalent
Bank of England Signals Interest Rates Likely to Remain Unchanged Despite Energy Market Risks
NHS Trusts Launch Job-Cutting Programmes as Financial Pressures Intensify Across England
More Than 130 Labour MPs Urge Ban on Trade With Israeli Settlements
Keir Starmer Orders Technology Firms to Introduce Smartphone Nudity Controls for Under-18s
UK Unveils £400 Million National AI Supercomputer Fund and New Economics Institute
Japanese Technology Firm Fujitsu Launches Advanced Artificial Intelligence Tool for Corporate Disclosures
South Africa Officially Launches Nationwide Campaign for Highly Contested Local Government Elections
United Kingdom Commits Additional Funding for Unexploded Ordnance Clearance in Laos
Singapore Announces Stringent New Greenhouse Gas Regulations for Commercial Cooling Systems
Cambodia and Thailand Hold High-Level Border Security Talks at United Nations Headquarters
Myanmar Military Government and China Sign Major Agreement to Upgrade Media and Cultural Cooperation
×